SD-1029 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as an inhibitor targeting specific enzymes involved in cell proliferation and survival pathways. This makes it a valuable compound for investigating potential treatments for various types of cancers, as it helps in understanding the mechanisms of tumor growth and resistance to existing therapies. Additionally, SD-1029 is employed in preclinical studies to evaluate its efficacy and safety profile, aiding in the development of novel anticancer drugs. Its role in modulating cellular pathways also extends to research in other diseases where abnormal cell growth is a key factor.